BC Stock Analysis: Brunswick | NYSE
Recreational Vehicles | NYSE, USA | Market Cap: 5.004m USD | 12M Return: 27.4% | US1170431092 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 60.1M
EPS Trend: -78.2%
Qual. Beats: 3
Rev. Trend: -40.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brunswick Corporation (NYSE: BC) is a global recreation products company headquartered in Mettawa, Illinois, that operates through four business segments: Propulsion, Engine Parts & Accessories (P&A), Navico Group, and Boat. The Propulsion segment produces outboard, sterndrive, and inboard engines under the Mercury family of brands, while the Engine P&A segment distributes replacement parts, oils, and accessories through aftermarket and OEM channels. The Navico Group supplies marine electronics, sensors, control systems, and power systems for marine, RV, specialty vehicle, and industrial markets under brands such as Lowrance, Simrad, B&G, Mastervolt, and CZone. The Boat segment manufactures recreational vessels under brands including Sea Ray, Boston Whaler, Bayliner, Lund, and Crestliner, and operates the Freedom Boat Club franchise.
Founded in 1845, Brunswick is one of the oldest and most vertically integrated players in the recreational marine industry, controlling capability across engine manufacturing, marine electronics, parts distribution, and boatbuilding. The company is classified within the Consumer Discretionary sector under the Leisure Products sub-industry and trades as a mid-cap stock on the NYSE.
- Mercury outboard share gains lift Propulsion segment margins
- RV softness pressures Navico electronics revenue growth
- Interest rates curb big-ticket boat demand and dealer orders
| Net Income: 211.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -4.02 > 1.0 |
| NWC/Revenue: 12.90% < 20% (prev 18.18%; Δ -5.28% < -1%) |
| CFO/TA 0.10 > 3% & CFO 571.1m > Net Income 211.1m |
| Net Debt (2.12b) to EBITDA (637.5m): 3.33 < 3 |
| Current Ratio: 1.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.1m) vs 12m ago -0.91% < -2% |
| Gross Margin: 26.22% > 18% (prev 23.54%; Δ 2.68% > 0.5%) |
| Asset Turnover: 105.5% > 50% (prev 95.76%; Δ 9.71% > 0%) |
| Interest Coverage Ratio: 3.50 > 6 (EBIT TTM 340.7m / Interest Expense TTM 97.3m) |
| A: 0.14 (Total Current Assets 2.18b - Total Current Liabilities 1.44b) / Total Assets 5.44b |
| B: 0.64 (Retained Earnings 3.47b / Total Assets 5.44b) |
| C: 0.06 (EBIT TTM 340.7m / Avg Total Assets 5.43b) |
| D: 0.45 (Book Value of Equity 1.69b / Total Liabilities 3.75b) |
| Altman-Z'' = 3.87 = AA |
| DSRI: 0.96 (Receivables 519.3m/491.4m, Revenue 5.72b/5.18b) |
| GMI: 0.90 (GM 23.54% / 26.22%) |
| AQI: 0.99 (AQ_t 0.34 / AQ_t-1 0.34) |
| SGI: 1.10 (Revenue 5.72b / 5.18b) |
| TATA: -0.07 (NI 211.1m - CFO 571.1m) / TA 5.44b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of November 10, 2026, the stock is trading at USD 79.68 with a total of 727,788 shares traded. Over the past week, the price has changed by +0.80%, over one month by +29.60%, over three months by -0.40% and over the past year by +27.39%.
Current recommended Stop Loss: 76.30 (which is 4.2% or 1.2 ATR below the current price).
Brunswick has received a consensus analysts rating of 3.95. Therefore, it is recommended to buy BC.
- StrongBuy: 9
- Buy: 0
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 87.7 | 10.1% |
P/E Trailing = 24.2862
P/E Forward = 14.6843
P/S = 0.8743
P/B = 3.0241
P/EG = 0.7212
Revenue TTM = 5.72b USD
EBIT TTM = 340.7m USD
EBITDA TTM = 637.5m USD
Long Term Debt = 1.81b USD (from longTermDebt, last fiscal year)
Short Term Debt = 195.1m USD (from shortTermDebt, last quarter)
Debt = 2.39b USD (from shortLongTermDebtTotal, last quarter) + Leases 190.2m
Net Debt = 2.12b USD (calculated: Debt 2.39b - CCE 268.6m)
Enterprise Value = 7.13b USD (5.00b + Debt 2.39b - CCE 268.6m)
Interest Coverage Ratio = 3.50 (Ebit TTM 340.7m / Interest Expense TTM 97.3m)
EV/FCF = 19.11x (Enterprise Value 7.13b / FCF TTM 372.9m)
FCF Yield = 5.23% (FCF TTM 372.9m / Enterprise Value 7.13b)
FCF Margin = 6.52% (FCF TTM 372.9m / Revenue TTM 5.72b)
Net Margin = 3.69% (Net Income TTM 211.1m / Revenue TTM 5.72b)
Gross Margin = 26.22% ((Revenue TTM 5.72b - Cost of Revenue TTM 4.22b) / Revenue TTM)
Gross Margin QoQ = 28.32% (prev 28.10%)
Tobins Q-Ratio = 1.31 (Enterprise Value 7.13b / Total Assets 5.44b)
Interest Expense / Debt = 4.07% (Interest Expense 97.3m / Debt 2.39b)
Taxrate = 12.33% (30.0m / 243.4m)
NOPAT = 298.7m (EBIT 340.7m * (1 - 12.33%))
Current Ratio = 1.51 (Total Current Assets 2.18b / Total Current Liabilities 1.44b)
Debt / Equity = 1.41 (Debt 2.39b / totalStockholderEquity, last quarter 1.69b)
Debt / EBITDA = 3.33 (Net Debt 2.12b / EBITDA 637.5m)
Debt / FCF = 5.69 (Net Debt 2.12b / FCF TTM 372.9m)
Total Stockholder Equity = 1.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 211.1m / Total Assets 5.44b)
RoE = 12.95% (Net Income TTM 211.1m / Total Stockholder Equity 1.63b)
RoCE = 9.91% (EBIT 340.7m / Capital Employed (Equity 1.63b + L.T.Debt 1.81b))
RoIC = 7.62% (NOPAT 298.7m / Invested Capital 3.92b)
WACC = 8.19% (E(5.00b)/V(7.39b) * Re(10.39%) + D(2.39b)/V(7.39b) * Rd(4.07%) * (1-Tc(0.12)))
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.52 | Cagr: -1.66%
[DCF] Terminal Value 73.10% ; FCFF base≈459.3m ; Y1≈402.7m ; Y5≈325.4m
[DCF] Fair Price = 47.87 (EV 5.22b - Net Debt 2.12b = Equity 3.10b / Shares 64.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -78.23 | EPS CAGR: -27.66% | SUE: 1.62 | # QB: 3
Revenue Correlation: -40.58 | Revenue CAGR: -3.10% | SUE: 0.01 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.87 | Chg30d=-1.63% | Revisions=+17% | Analysts=11
EPS current Year (2026-12-31): EPS=4.61 | Chg30d=+1.10% | Revisions=+36% | GrowthEPS=+41.0% | GrowthRev=+7.4%
EPS next Year (2027-12-31): EPS=5.42 | Chg30d=-0.06% | Revisions=+15% | GrowthEPS=+17.5% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: +29% (up=14, down=7)